ARCHIVES

Lung Cancer Clinical Trials Cost-Effective Alternative

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

June 10, 1988

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

In Brief: Philadelphia Chromosome Discoverer Hungerford Dead; Oregon Recruits Scientists

November 12, 1993

ICCCR Issues RFP For Cancer Risk Scale

March 6, 1992